AF
MDT icon

Abound Financial’s Medtronic MDT Stock Holding History

Abound Financial’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.02K Hold
77
– – ﹤0.01% 247
2026
Q1 		$6.67K Hold
77
– – ﹤0.01% 226
2025
Q4 		$7.4K Buy
+77
New +$7.48K ﹤0.01% 220
2025
Q2 		– Sell
-77
Closed -$6.92K – 182
2025
Q1 		$6.92K Buy
+77
New +$6.89K ﹤0.01% 217

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Abound Financial's MDT Position: Q2 2026 in Review

Abound Financial held its Medtronic (MDT) position steady in Q2 2026 at 77 shares worth $6.02K. The position accounts for ﹤0.01% of the portfolio, ranked #247.

Abound Financial first reported a position in MDT in Q1 2025 and has held it in 4 quarters since. The position peaked at $7.4K in Q4 2025. 2,138 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Abound Financial held 77 shares of Medtronic worth $6.02K as of Q2 2026.
  • Abound Financial left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up ﹤0.01% of Abound Financial's portfolio in Q2 2026, its #247 holding.
  • Abound Financial first reported a position in Medtronic in Q1 2025 and has held it in 4 quarters since.
  • Abound Financial's Medtronic position peaked at $7.4K in Q4 2025.
  • 2,138 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Abound Financial's 13F filing for Q2 2026, filed 14 Aug 2026.